renal/urinary system
N |
• mice do not show any developmental abnormalities or changes in kidney/body weight and exhibit no increase in proteinuria levels after 18 months
|
albuminuria
(
J:345639
)
• mice with STZ-induced type I diabetic nephropathy show increased albumin/creatinine ratio
|
• podocyte foot processes show an increase in widening and misconfiguration in mice with STZ-induced type I diabetic nephropathy compared to controls
|
• mice with STZ-induced type I diabetic nephropathy show decreased slit diaphragm density and slit diaphragms that are partially translocated to proximal parts of food processes compared to controls
|
homeostasis/metabolism
• autophagy is impaired in mice with STZ-induced type I diabetic nephropathy
|
albuminuria
(
J:345639
)
• mice with STZ-induced type I diabetic nephropathy show increased albumin/creatinine ratio
|
• mice intraperitoneally injected with streptozotocin (STZ) to induce type I diabetes develop increased albuminuria and mild nephropathy (glomerular hypertrophy, hyperfiltration) but no differences in kidney weight/body weight ratios, in blood glucose levels, or in glomerular sclerosis compared to controls
|
cellular
• autophagy is impaired in mice with STZ-induced type I diabetic nephropathy
|